Novozymes A/S - Company Profile (NASDAQ:NVZMY)

About Novozymes A/S - (NASDAQ:NVZMY)

Novozymes A/S - logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVZMY
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $42.76
  • 200 Day Moving Avg: $38.24
  • 52 Week Range: $31.57 - $49.55
  • Trailing P/E Ratio: 29.89
  • Foreward P/E Ratio: 25.28
  • P/E Growth: 23.69
Sales & Book Value:
  • Annual Revenue: $2.09 billion
  • Price / Sales: N/A
  • Book Value: $5.40 per share
  • Price / Book: 8.29
  • Dividend Yield: 1.3%
  • EBIDTA: $735.1 million
  • Average Volume: 21,297 shs.

Frequently Asked Questions for Novozymes A/S - (NASDAQ:NVZMY)

What is Novozymes A/S -'s stock symbol?

Novozymes A/S - trades on the NASDAQ under the ticker symbol "NVZMY."

How were Novozymes A/S -'s earnings last quarter?

Novozymes A/S - (NASDAQ:NVZMY) released its quarterly earnings results on Wednesday, April, 26th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. The business earned $535.97 million during the quarter. View Novozymes A/S -'s Earnings History.

Where is Novozymes A/S -'s stock going? Where will Novozymes A/S -'s stock price be in 2017?

6 equities research analysts have issued 12-month price objectives for Novozymes A/S -'s shares. Their predictions range from $47.50 to $47.50. On average, they anticipate Novozymes A/S -'s stock price to reach $47.50 in the next twelve months. View Analyst Ratings for Novozymes A/S -.

Who are some of Novozymes A/S -'s key competitors?

How do I buy Novozymes A/S - stock?

Shares of Novozymes A/S - can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Novozymes A/S - stock cost?

One share of Novozymes A/S - stock can currently be purchased for approximately $44.75.

Analyst Ratings

Consensus Ratings for Novozymes A/S - (NASDAQ:NVZMY) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $47.50 (6.15% upside)

Analysts' Ratings History for Novozymes A/S - (NASDAQ:NVZMY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/9/2017Jefferies Group LLCReiterated RatingHold$47.50MediumView Rating Details
2/10/2017JPMorgan Chase & Co.DowngradeOverweight -> NeutralN/AView Rating Details
2/1/2017Goldman Sachs Group IncDowngradeNeutral -> SellN/AView Rating Details
1/5/2017Sanford C. BernsteinUpgradeMarket Perform -> OutperformN/AView Rating Details
11/1/2016Berenberg BankUpgradeSell -> HoldN/AView Rating Details
10/7/2016Deutsche Bank AGInitiated CoverageHoldN/AView Rating Details
(Data available from 5/28/2015 forward)


Earnings History for Novozymes A/S - (NASDAQ:NVZMY)
Earnings by Quarter for Novozymes A/S - (NASDAQ:NVZMY)
Earnings History by Quarter for Novozymes A/S - (NASDAQ:NVZMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/20173/31/2017$0.36$0.37$535.97 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Novozymes A/S - (NASDAQ:NVZMY)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.77 EPS


Dividend History for Novozymes A/S - (NASDAQ:NVZMY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Novozymes A/S - (NASDAQ:NVZMY)
No insider trades for this company have been tracked by


Headline Trends for Novozymes A/S - (NASDAQ:NVZMY)
Latest Headlines for Novozymes A/S - (NASDAQ:NVZMY)



Novozymes A/S - (NVZMY) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by Staff